GLTO
Price
$3.01
Change
+$0.01 (+0.33%)
Updated
Sep 5 closing price
Capitalization
3.99M
VYNE
Price
$0.30
Change
-$0.01 (-3.23%)
Updated
Sep 5 closing price
Capitalization
7.62M
Interact to see
Advertisement

GLTO vs VYNE

Header iconGLTO vs VYNE Comparison
Open Charts GLTO vs VYNEBanner chart's image
Galecto
Price$3.01
Change+$0.01 (+0.33%)
Volume$7.34K
Capitalization3.99M
VYNE Therapeutics
Price$0.30
Change-$0.01 (-3.23%)
Volume$2.09M
Capitalization7.62M
GLTO vs VYNE Comparison Chart in %
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. VYNE commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Hold and VYNE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (GLTO: $3.01 vs. VYNE: $0.30)
Brand notoriety: GLTO and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 36% vs. VYNE: 84%
Market capitalization -- GLTO: $3.99M vs. VYNE: $7.62M
GLTO [@Biotechnology] is valued at $3.99M. VYNE’s [@Biotechnology] market capitalization is $7.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileVYNE’s FA Score has 2 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • VYNE’s FA Score: 2 green, 3 red.
According to our system of comparison, VYNE is a better buy in the long-term than GLTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 4 TA indicator(s) are bullish while VYNE’s TA Score has 4 bullish TA indicator(s).

  • GLTO’s TA Score: 4 bullish, 5 bearish.
  • VYNE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VYNE is a better buy in the short-term than GLTO.

Price Growth

GLTO (@Biotechnology) experienced а -5.35% price change this week, while VYNE (@Biotechnology) price change was -6.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYNE($7.62M) has a higher market cap than GLTO($3.99M). GLTO YTD gains are higher at: -35.269 vs. VYNE (-91.069). GLTO has higher annual earnings (EBITDA): -16.94M vs. VYNE (-42.58M). VYNE has more cash in the bank: 39.6M vs. GLTO (10.2M). VYNE has less debt than GLTO: VYNE (25K) vs GLTO (75K). VYNE has higher revenues than GLTO: VYNE (476K) vs GLTO (0).
GLTOVYNEGLTO / VYNE
Capitalization3.99M7.62M52%
EBITDA-16.94M-42.58M40%
Gain YTD-35.269-91.06939%
P/E RatioN/A0.71-
Revenue0476K-
Total Cash10.2M39.6M26%
Total Debt75K25K300%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLTOVYNE
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 5 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YORW31.010.27
+0.88%
York Water Company
ATHE5.07N/A
N/A
Alterity Therapeutics Limited
TMC5.12N/A
N/A
TMC the metals company
AEG7.52-0.03
-0.40%
Aegon Ltd
DRMA5.26-0.24
-4.42%
Dermata Therapeutics Inc

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with TCRT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+0.33%
TCRT - GLTO
56%
Loosely correlated
N/A
VIVS - GLTO
38%
Loosely correlated
+11.06%
SYRE - GLTO
37%
Loosely correlated
+0.06%
AURA - GLTO
36%
Loosely correlated
+0.93%
DNLI - GLTO
36%
Loosely correlated
+4.33%
More

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with NEVPF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
-3.64%
NEVPF - VYNE
52%
Loosely correlated
N/A
SYRE - VYNE
36%
Loosely correlated
+0.06%
ABVX - VYNE
34%
Loosely correlated
+2.90%
EYPT - VYNE
33%
Loosely correlated
+17.93%
GLTO - VYNE
30%
Poorly correlated
+0.33%
More